TY - JOUR
T1 - Integrating risk profiles for disease progression in the treatment choice for patients with lower urinary tract symptoms/benign prostatic hyperplasia
T2 - A combined analysis of external evidence and clinical expertise
AU - Speakman, M.
AU - Batista, J.
AU - Berges, R.
AU - Chartier-Kastler, E.
AU - Conti, G.
AU - Desgrandchamps, F.
AU - Dreikorn, K.
AU - Lowe, F.
AU - O'Leary, M.
AU - Perez, M.
AU - Trachtenberg, J.
AU - Tubaro, A.
AU - Meesen, B.
AU - Smets, L.
AU - Stoevelaar, H.
PY - 2005/12
Y1 - 2005/12
KW - Benign prostatic hyperplasia
KW - Evidence-based medicine
KW - Lower urinary tract symptoms
KW - RAND appropriateness method
KW - Risk factors
UR - https://www.scopus.com/pages/publications/30544436072
UR - https://www.scopus.com/pages/publications/30544436072#tab=citedBy
U2 - 10.1038/sj.pcan.4500827
DO - 10.1038/sj.pcan.4500827
M3 - Article
C2 - 16130013
AN - SCOPUS:30544436072
SN - 1365-7852
VL - 8
SP - 369
EP - 374
JO - Prostate Cancer and Prostatic Diseases
JF - Prostate Cancer and Prostatic Diseases
IS - 4
ER -